U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 28 - February 3, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 28 - February 3, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 01/29/2024
Location: Bethesda, MD
Subject: 10th Annual NIH-Gates Foundation Leadership Workshop on Global Health
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants

Event Date: 01/30/2024
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Ilisa Bernstein, Michael D. Hogue (American Pharmacists Association (APhA));

Event Date: 01/31/2024
Location: Washington, DC
Subject: HHS Food is Medicine (FIM) Summit: Department of HHS Collaboration and Investments in FIM
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other invited participants

Event Date: 02/01/2024
Location: Petersburg, VA
Subject: Civica Manufacturing Facility Site Visit
FDA Participant/Group: BROOKE COURTNEY; HILARY MARSTON;
Non FDA Participant/Group: Several Civica leadership and staff

Event Date: 02/02/2024
Location: Virtual
Subject: Regulatory Approaches for AI-Based Clinical Decision Support
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Ravi B. Parikh (University of Pennsylvania); Gilbert S. Omenn (University of Michigan);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 01/29/2024
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: FDA Foods Coalition members, which include consumer advocates, industry trade associations, public health groups state and local regulators, and individual food policy experts

Event Date: 01/30/2024
Location: Washington, DC
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Food and Beverage Issue Alliance

Event Date: 01/31/2024
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Ardent Mills’ executive leadership team

Event Date: 02/01/2024
Location: College Park, MD
Subject: Listening Session: Food and Chemical Safety Issues
FDA Participant/Group: JESSICA ROWDEN; STEVEN MUSSER; KRISTI MULDOON JACOBS;
Non FDA Participant/Group: Maria J. Doa, Maricel Maffini (Environmental Defense Fund);

Event Date: 02/01/2024
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Safe Food Coalition

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/29/2024
Location: Virtual
Subject: Harmonization of Regulations and Guidance Governing the Inclusion of Pregnant Women in Clinical Research
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Coalition of Advance Maternal Therapeutics (CAMT) members

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/02/2024
Location: Virtual
Subject: Series in Advancements in Cell Therapy Asia Pacific Cell Therapy Conference: Guiding the Development of the Next Wave of CAR (Chimeric Antigen Receptor)-T Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and research stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/01/2024
Location: Washington, DC
Subject: Friends of Cancer Research: The Future of Diagnostic Tests: New Data & Modern Policy: Keynote Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders

Event Date: 02/02/2024
Location: Virtual
Subject: Academic Collaborations to Study and Optimize Regulatory Approaches for AI-Based Clinical Decision Support
FDA Participant/Group: BRITTANY JACOBS; ROBERT CALIFF; CATHERINE BAHR;
Non FDA Participant/Group: Gilbert Omenn (University of Michigan); Ravi Parikh (University of Pennsylvania);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 01/29/2024
Location: National Harbor, MD
Subject: Substance Abuse and Mental Health Services’ (SAMHSA) 20th Prevention Day; Speaker: FDA’s Comprehensive Approach to Tobacco Product Regulation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, academia, community outreach, and other stakeholders

Event Date: 01/29/2024
Location: Silver Spring, MD
Subject: Listening Session; Juul Labs Inc. (JLI)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives of JUUL Labs, Inc.

Event Date: 01/29/2024
Location: Virtual
Subject: Keller and Heckman E-Vapor Tobacco and Law Symposium; Keynote Address: FDA’s Comprehensive Approach to Tobacco Product Regulation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and other registered attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top